Ambisense today announced its entry into the air quality market with the launch of AmbiAir, a solution designed to help manage, assess, and predict the COVID-19 risk in commercial and public buildings.
‘As a company, we’re always looking to use our technological expertise to develop solutions for pressing geo-environmental problems. This led us to create AmbiAir, a product designed to help keep people as safe as possible in these trying times, and as a complement to established approaches such as social distancing.’
Stephen McNulty, Ambisense founder & CEO
By increasing building ventilation, and combining it with measures such as social distancing, we can decrease the COVID-19 risk that we face in public spaces. Studies show that the danger of exposure to COVID-19 is reduced when the level of CO2 is below 600ppm, relative humidity is between 40-60%, and there are no or very minimal levels of PM2.5.
AmbiAir is a low-cost solution that combines discreet, multi-deployable hardware with Ambilytics, an intelligent platform that digs through the vast quantities of location-based data to quickly and easily understand the performance of the critical risk drivers, identifying risk hot-spots in real-time, and predicting when safe levels are likely to be breached.
The first in a range of air quality solutions being released this year, AmbiAir combines multiple tools and techniques useful to air quality professionals to understand the behaviour of air quality pollutants.